• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

dextera

B. Braun’s Aesculap closes $17m Dextera Surgical bankruptcy buyout

February 22, 2018 By Brad Perriello

Surgical instrument maker Dextera Surgical and B. Braun subsidiary Aesculap said yesterday that they closed the $17.3 million deal to buy Dextera out of Chapter 11 bankruptcy. Redwood City, Calif.- based Dextera, formerly known as Cardica, agreed to the buyout in December 2017. The consummation Feb. 20 saw Dextera receive $13.6 million; another $2 million went into two-year escrow, $900,000 went to repay […]

Filed Under: Mergers & Acquisitions, Surgical, Wall Street Beat Tagged With: aesculap, B. Braun, Bankruptcy, dextera

B. Braun’s Aesculap to buy Dextera Surgical out of bankruptcy for $17m

December 18, 2017 By Brad Perriello

B. Braun subsidiary Aesculap agreed to pay $17.3 million to buy surgical instrument maker Dextera Surgical (NSDQ:DXTR) out of Chapter 11 bankruptcy, provided no other suitors emerge. Redwood City, Calif.- based Dextera, formerly known as Cardica, said the Dec. 11 deal calls for $2 million to be put into escrow for two years to cover any indemnification […]

Filed Under: Mergers & Acquisitions, Surgical, Wall Street Beat Tagged With: Aesculap Implant Systems, B. Braun, Bankruptcy, dextera

Dextera shares fall on Q3 prelim sales miss

October 5, 2017 By Fink Densford

Dextera Surgical (NSDQ:DXTR) today has seen shares fall more than 10% after releasing its preliminary earnings for the 3rd quarter, expecting to see revenue of approximately $568,000. Analysts on Wall Street were expecting to see sales of around $1.1 million for the company, significantly higher than the preliminary numbers released. The Redwood City, Calif.-based company said […]

Filed Under: Business/Financial News Tagged With: dextera

Dextera Surgical wins expanded FDA nod for MicroCutter 5/80 stapler

August 31, 2017 By Fink Densford

Dextera Surgical (NSDQ:DXTR) said today it won expanded FDA 510(k) clearance for its MicroCutter 5/80 stapler and associated reloads, now cleared for open solid organ parenchymal dissection techniques. The new clearance covers use on organs including the liver, kidney, pancreas and spleen, the Redwood City, Calif.-based company said. “The small size and large degree of articulation […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance, Surgical Tagged With: dextera

Dextera plummets on shipping hold, Q4 miss

July 7, 2017 By Brad Perriello

Share prices for Dextera Surgical (NSDQ:DXTR) plunged today after the surgical instruments maker announced a shipping hold on its MicroCutter 5/80 stapler and missed expectations with its fiscal fourth-quarter and 2017 preliminary sales numbers. Redwood City, Calif.-based Dextera, formerly known as Cardica, said it put the hold on the MicroCutter 5/80 and its reload cartridges […]

Filed Under: MassDevice Earnings Roundup, Recalls, Surgical, Wall Street Beat Tagged With: dextera

7 medtech stories we missed this week: June 2, 2017

June 2, 2017 By Danielle Kirsh

From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The […]

Filed Under: Business/Financial News, Clinical Trials, News Well, Regulatory/Compliance, Research & Development Tagged With: c2 Therapeutics, dextera, DreaMed Diabetes, endogastricsolutions, Implandata, Inolife, MicroTransponder Inc.

Dextera closes $8m offering

May 19, 2017 By Fink Densford

Dextera Surgical (NSDQ:DXTR) said today it closed an $8 million public offering of Series B convertible preferred stock to support its MicroCutter 5/80 stapler. In the offering, Redwood City, Calif.-based Dextera Surgical offered 8,000 shares of Series B convertible preferred stock and related warrants at $1,000 per share. Each share of Series B stock, convertible into […]

Filed Under: Business/Financial News, Surgical Tagged With: dextera

Dextera prices $8m offering

May 12, 2017 By Fink Densford

Dextera Surgical (NSDQ:DXTR) today priced an upcoming underwritten public offering, looking to raise approximately $8 million. In the offering, Redwood City, Calif.-based Dextera Surgical will offer 8,000 shares of Series B convertible preferred stock and related warrants at $1,000 per share. The offering is expected to close May 16, the company said. Each share of Series […]

Filed Under: Blog Tagged With: dextera

Study: Dextera touts shorter hospital stays for MI lobectomy procedures using its MicroCutter stapler

March 6, 2017 By Fink Densford

Dextera Surgical (NSDQ:DXTR) today released data from a small study of patients who underwent microlobectomy procedures utilizing its MicroCutter surgical stapler, touting hospital stays at least 2 days lower than open lobectomy procedures. “The interest in the presentation at the meeting reflects the global interest in technologies like the MicroCutter 5/80 that enable less invasive approaches […]

Filed Under: Clinical Trials, Surgical Tagged With: dextera

Dextera launches registry study of MicroCutter 5/80 stapler

December 12, 2016 By Fink Densford

Dextera Surgical (NSDQ:DXTR) said last week it launched a registry study of its MicroCutter 5/80 surgical stapler designed for hemostasis. The Redwood City, Calif.-based company said it enrolled the 1st U.S. patient in the study, which looks to enroll a total of 120 patients undergoing lung resections which require surgical stapling. The study will examine […]

Filed Under: Clinical Trials, Surgical Tagged With: dextera

Intuitive partners with Dextera on robotic surgery stapler

August 1, 2016 By Fink Densford

Intuitive Surgical (NSDQ:ISRG) said it inked a joint development deal with Dextera Surgical (NSDQ:DXTR) to develop a surgical stapler and cartridge for Intuitive’s da Vinci robotic surgical system. The company said the new development follows completion of a 6-month feasibility evaluation of Dextera’s MicroCutter as part of an ongoing deal between the companies. “This partnership with […]

Filed Under: Business/Financial News, Research & Development, Robotics, Surgical Tagged With: dextera, Intuitive Surgical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS